SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/11 – ‘EX-10.4’

On:  Tuesday, 8/9/11, at 4:36pm ET   ·   For:  6/30/11   ·   Accession #:  1193125-11-216590   ·   File #:  0-32085

Previous ‘10-Q’:  ‘10-Q’ on 5/9/11 for 3/31/11   ·   Next:  ‘10-Q’ on 11/9/11 for 9/30/11   ·   Latest:  ‘10-Q’ on 11/7/22 for 9/30/22   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/11  Allscripts Healthcare Soluti… Inc 10-Q        6/30/11   67:4.9M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    660K 
 2: EX-10.4     Form of Restricted Stock Unit Award Agreement for   HTML     39K 
                Non-Employee Directors                                           
 3: EX-10.5     Form of Time-Based Vesting Restricted Stock Unit    HTML     47K 
                Award Agreement for Employees                                    
 4: EX-18.1     Preferability Letter Dated August 9, 2011           HTML     22K 
 5: EX-31.1     Certification of Chief Executive Officer            HTML     26K 
 6: EX-31.2     Certification of Chief Financial Officer            HTML     26K 
 7: EX-32.1     Certification of Chief Executive Officer and Chief  HTML     21K 
                Financial Officer                                                
18: R1          Document And Entity Information                     HTML     40K 
60: R2          Consolidated Balance Sheets                         HTML    150K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
16: R4          Consolidated Statements Of Operations               HTML     93K 
52: R5          Consolidated Statements Of Cash Flows               HTML    148K 
35: R6          Basis Of Presentation And Significant Accounting    HTML     47K 
                Policies                                                         
56: R7          Business Combinations                               HTML     65K 
28: R8          Fair Value Measurements                             HTML     50K 
36: R9          Stockholders' Equity                                HTML     37K 
40: R10         Comprehensive Income                                HTML     39K 
48: R11         Basic And Diluted Earnings Per Share                HTML     51K 
22: R12         Goodwill And Intangible Assets                      HTML     64K 
34: R13         Debt                                                HTML     61K 
30: R14         Income Taxes                                        HTML     29K 
32: R15         Commitment With Strategic Partner                   HTML     25K 
57: R16         Business Segments                                   HTML     51K 
27: R17         Derivative Financial Instruments                    HTML     46K 
46: R18         Recent Accounting Pronouncements                    HTML     37K 
31: R19         Contingencies                                       HTML     40K 
59: R20         Basis Of Presentation And Significant Accounting    HTML     56K 
                Policies (Policy)                                                
49: R21         Business Combinations (Tables)                      HTML     53K 
53: R22         Fair Value Measurements (Tables)                    HTML     39K 
17: R23         Comprehensive Income (Tables)                       HTML     35K 
55: R24         Basic And Diluted Earnings Per Share (Tables)       HTML     49K 
26: R25         Goodwill And Intangible Assets (Tables)             HTML     63K 
20: R26         Debt (Tables)                                       HTML     46K 
23: R27         Business Segments (Tables)                          HTML     45K 
42: R28         Derivative Financial Instruments (Tables)           HTML     36K 
51: R29         Business Combinations (Narrative) (Details)         HTML     53K 
45: R30         Business Combinations (Schedule Of Purchase Price   HTML     31K 
                Of Acquisition) (Details)                                        
38: R31         Business Combinations (Summary Of Assets Acquired   HTML     48K 
                And Liabilities Assumed) (Details)                               
33: R32         Business Combinations (Schedule Of Acquired         HTML     32K 
                Intangible Assets Amortization) (Details)                        
43: R33         Business Combinations (Schedule Of Pro Forma        HTML     26K 
                Results) (Details)                                               
58: R34         Fair Value Measurements (Narrative) (Details)       HTML     20K 
29: R35         Fair Value Measurements (Summary Of Financial       HTML     40K 
                Assets Measured At Fair Value On Recurring Basis)                
                (Details)                                                        
61: R36         Stockholders' Equity (Narrative) (Details)          HTML     46K 
67: R37         Comprehensive Income (Components Of Comprehensive   HTML     52K 
                Income) (Details)                                                
25: R38         Basic And Diluted Earnings Per Share (Schedule Of   HTML     52K 
                Calculations Of Earning Per Share) (Details)                     
50: R39         Basic And Diluted Earnings Per Share (Antidilutive  HTML     26K 
                Securities Excluded From Computation Of Earnings                 
                Per Share) (Details)                                             
37: R40         Goodwill And Intangible Assets (Schedule Of         HTML     41K 
                Goodwill And Intangible Assets) (Details)                        
44: R41         Goodwill And Intangible Assets (Schedule Of         HTML     36K 
                Changed In The Carrying Amount Of Goodwill)                      
                (Details)                                                        
41: R42         Debt (Narrative) (Details)                          HTML     99K 
24: R43         Debt (Schedule Of Outstanding Debt) (Details)       HTML     27K 
54: R44         Debt (Schedule Of Interest Expense) (Details)       HTML     33K 
65: R45         Debt (Schedule Of Debt Maturities) (Details)        HTML     29K 
66: R46         Income Taxes (Details)                              HTML     30K 
21: R47         Commitment With Strategic Partner (Details)         HTML     28K 
19: R48         Business Segments (Details)                         HTML     27K 
64: R49         Derivative Financial Instruments (Narrative)        HTML     36K 
                (Details)                                                        
14: R50         Derivative Financial Instruments (Fair Value Of     HTML     23K 
                Derivative Instrument) (Details)                                 
39: R51         Derivative Financial Instruments (Fair Value Of     HTML     34K 
                Interest Rate Swap Agreement) (Detail)                           
62: XML         IDEA XML File -- Filing Summary                      XML    102K 
63: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    669K 
 8: EX-101.INS  XBRL Instance -- mdrx-20110630                       XML   1.00M 
10: EX-101.CAL  XBRL Calculations -- mdrx-20110630_cal               XML    158K 
11: EX-101.DEF  XBRL Definitions -- mdrx-20110630_def                XML    240K 
12: EX-101.LAB  XBRL Labels -- mdrx-20110630_lab                     XML    810K 
13: EX-101.PRE  XBRL Presentations -- mdrx-20110630_pre              XML    561K 
 9: EX-101.SCH  XBRL Schema -- mdrx-20110630                         XSD    132K 
47: ZIP         XBRL Zipped Folder -- 0001193125-11-216590-xbrl      Zip    106K 


‘EX-10.4’   —   Form of Restricted Stock Unit Award Agreement for Non-Employee Directors


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form of Restricted Stock Unit Award Agreement for Non-Employee Directors  

Exhibit 10.4

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

Restricted Stock Unit Award Agreement

(Directors)

THIS AGREEMENT is made as of %%OPTION DATE, ‘Month DD, YYYY”%-% (the “Grant Date”), by and between Allscripts Healthcare Solutions, Inc., a Delaware corporation (“Company”), and %%FIRST_NAME%-%         %%LAST_NAME%-%         (%%LAST_NAME%-%).

WHEREAS, %%LAST_NAME%-% is expected to perform valuable services for the Company as a member of the Board of Directors of the Company (the “Board”) and the Company considers it desirable and in its best interests that %%LAST_NAME%-% be given a proprietary interest in the Company and an incentive to advance the interests of the Company by possessing units that are settled in shares of the Company’s Common Stock, $.01 par value per share (the “Common Stock”), in accordance with the Company’s 2011 Stock Incentive Plan (the “Plan”).

NOW THEREFORE, in consideration of the foregoing premises, it is agreed by and between the parties as follows:

 

1. Grant of Restricted Stock Units.

 

  (a) Grant. Subject to the terms and conditions set forth in this Agreement and the Plan, the Company hereby grants to %%LAST_NAME%-% an award of          restricted stock units (the “Restricted Stock Unit Award”), which shall vest and become unrestricted in accordance with Sections 2 and 4 hereof.

 

  (b) Transferability. Restricted stock units subject to the Restricted Stock Unit Award and not then vested and unrestricted may not be sold, transferred, pledged, assigned, alienated, hypothecated, encumbered or otherwise disposed of (whether by operation of law or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, alienate, hypothecate or encumber, or otherwise dispose of such restricted stock units, the Restricted Stock Unit Award shall immediately become null and void.

 

2. Vesting.

 

  (a)

Time Vesting. Subject to Sections 2(b), 2(c) and 4, the restricted stock units subject to the Restricted Stock Unit Award shall vest and become unrestricted in accordance with the following schedule: Vesting shall occur in twelve (12) equal monthly installments, commencing on the last day of the month in which the Grant Date occurs and ending on the last day of the month which is eleven (11) months following the month in which the Grant Date occurs; provided, however, that if the Company’s 2012 annual meeting of stockholders occurs prior to the time that all restricted stock units subject to the Restricted Stock Unit Award are vested, the restricted stock units which are unvested on the date of such annual


meeting of stockholders shall immediately vest and become unrestricted on the date of such annual meeting of stockholders. Upon such vesting the shares of Common Stock underlying the vested restricted stock units shall not be issued, but the issuance of such shares instead shall be deferred in accordance with Section 2(c).

 

  (b) Accelerated Vesting. If %%LAST_NAME%-% continues to be a director of the Company from the date of this Agreement until the occurrence of a Change of Control (as defined in the Plan), the portion of the Restricted Stock Unit Award which has not become vested and unrestricted under Section 2(a) at the date of such event shall immediately vest and become unrestricted with respect to 100% of the restricted stock units subject to this Restricted Stock Unit Award simultaneously with the consummation of the Change of Control and upon such vesting the shares of Common Stock underlying the vested restricted stock units shall be issued to %%LAST_NAME%-%.

 

  (c) Deferral of Settlement of Restricted Stock Units. Except as otherwise provided in Section 2(b), upon the date restricted stock units subject to this Agreement become vested and unrestricted, the shares of Common Stock underlying the restricted stock units shall not be issued, but the issuance of such shares shall instead be deferred until the Distribution Date. For purposes of this Agreement, “Distribution Date” means the date which is the earliest of (i) the fourth anniversary of the Grant Date, unless %%LAST_NAME%-% filed an election with the Company in accordance with the Company’s policies and applicable law to have the issuance of such shares deferred until %%LAST_NAME%-% ceases to be a director of the Company even if such cessation occurs later than the fourth anniversary of the Grant Date, (ii) five (5) business days following the date on which %%LAST_NAME%-% ceases to be a director of the Company and (iii) the date of consummation of a Change of Control. On the Distribution Date, one share of Common Stock shall be issuable for each vested restricted stock unit, subject to the terms and conditions of the Plan and this Agreement and the Company will issue such shares of Common Stock to %%LAST_NAME%-%.

 

 

3.

No Rights as Stockholder; Dividend Equivalents. %%LAST_NAME%-% shall not have any rights of a stockholder of the Company with respect to any shares of Common Stock underlying the restricted stock units subject to this Agreement (including the right to vote and to receive dividends and other distributions paid with respect to shares of Common Stock), unless and until, and only to the extent, the Restricted Stock Unit Award is settled by the issuance of such shares of Common Stock to %%LAST_NAME%-% on the Distribution Date. Notwithstanding the foregoing, until such time as such shares of Common Stock are issued, or the restricted stock units subject to this Agreement are cancelled, whichever occurs first, %%LAST_NAME%-% will be credited with amounts equal to any cash dividends that would be payable to %%LAST_NAME%-% if such underlying shares of Common Stock had been issued to %%LAST_NAME%-%, which amounts shall accrue until the Distribution Date and be paid in cash on the Distribution Date. If restricted stock units subject to this Agreement are cancelled, any amounts credited to such units will be forfeited. This Section 3 will

 

2


  not apply with respect to record dates for dividends occurring prior to the Grant Date or after the Distribution Date.

 

4. Termination of Unvested Restricted Stock Unit Award. If %%LAST_NAME%-%‘s service as a director of the Company terminates by reason of the death or disability of %%LAST_NAME%-%, the portion of the Restricted Stock Unit Award which is not vested and unrestricted as of the date of termination shall immediately vest and become unrestricted. If %%LAST_NAME%-%‘s service as a director of the Company terminates for any other reason, the portion of the Restricted Stock Unit Award which is not vested and unrestricted as of the date of termination shall be forfeited by %%LAST_NAME%-%, such portion shall be cancelled by the Company and %%LAST_NAME%-% shall promptly return this Agreement to the Company for cancellation and agrees to execute any document required by the Company in connection with such forfeiture. Such cancellation shall be effective regardless of whether %%LAST_NAME%-% returns this Agreement.

 

5. Adjustment in Event of Happening of Condition.

In the event that there is any change in the number of issued shares of Common Stock of the Company without new consideration to the Company (such as by stock dividends or stock split-ups), then the number of restricted stock units subject to this Restricted Stock Unit Award that are unvested or vested and deferred shall be adjusted in proportion to such change in issued shares.

If the outstanding shares of Common Stock of the Company shall be combined, or be changed into another kind of stock of the Company or into equity securities of another corporation, whether through recapitalization, reorganization, sale, merger, consolidation, etc., the Company shall cause adequate provision to be made whereby the restricted stock units subject to this Agreement that are unvested or vested and deferred shall be adjusted equitably so that the securities received upon distribution shall be the same as if the distribution had occurred immediately prior to such recapitalization, reorganization, sale, merger, consolidation, etc.

Notwithstanding the foregoing, in the event of a sale of the Company through a merger, consolidation or sale of all or substantially all of its assets where all or part of the consideration is stock, cash or other securities or property (where such event is not a Change of Control as defined in Section 2(b) above) (a “Transaction”), the restricted stock units subject to the Restricted Stock Unit Award, whether unvested or vested and deferred, shall be assumed or an award of equivalent value shall be substituted by the successor corporation or a parent or subsidiary of the successor corporation. In the event that the successor corporation refuses to assume or substitute for the Restricted Stock Unit Award, then simultaneously with the consummation of the Transaction, %%LAST_NAME%-% shall fully vest in the Restricted Stock Unit Award and all restricted stock units subject to the Restricted Stock Unit Award shall become unrestricted. For the purposes of this Section 5, the Restricted Stock Unit Award shall be considered assumed if, following the Transaction, the Restricted Stock Unit Award confers the right to receive, for each restricted stock unit subject to the Restricted Stock

 

 

3


Unit Award which immediately prior to the Transaction is unvested or vested and deferred, the consideration (whether stock, cash, or other securities or property) received in the Transaction by holders of Common Stock held on the effective date of the Transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares); provided, however, that if such consideration received in the Transaction is not solely common stock of the successor company, the Committee may, with the consent of the successor company, provide that the consideration to be received upon the distribution of the Restricted Stock Unit Award, for each share of Common Stock subject thereto, will be solely common stock of the successor company substantially equal in fair market value to the per share consideration received by holders of shares of Common Stock in the Transaction. The determination of such substantial equality of value of consideration shall be made by the Committee in its sole discretion and its determination shall be conclusive and binding.

 

6. Provisions of Plan. This Restricted Stock Unit Award is granted pursuant to, and subject to the terms and conditions of, the Plan (which is incorporated herein by reference). In the event a provision of this Agreement conflicts with the Plan, the terms of the Plan will prevail. %%LAST_NAME%-% acknowledges receiving a copy of the Plan and this Agreement. Any capitalized term not defined herein shall have the same meaning as in the Plan.

 

7. Section 409A. This Agreement is intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and shall be interpreted and construed consistently with such intent. In the event the terms of this Agreement would subject %%LAST_NAME%-% to taxes or penalties under Section 409A of the Code (“409A Penalties”), the Company and %%LAST_NAME%-% shall cooperate diligently to amend the terms of this Agreement to avoid such 409A Penalties, to the extent possible; provided that in no event shall the Company be responsible for any 409A Penalties that arise in connection with any amounts payable under this Agreement. To the extent any amounts under this Agreement are payable by reference to %%LAST_NAME%-%‘s “ceasing to be a director of the Company,” such term shall be deemed to refer to %%LAST_NAME%-%‘s “separation from service,” within the meaning of Section 409A of the Code. Notwithstanding any other provision in this Agreement, if %%LAST_NAME%-% is a “specified employee,” as defined in Section 409A of the Code, as of the date of %%LAST_NAME%-%‘s separation from service, then to the extent any amount payable to %%LAST_NAME%-% (i) is payable upon %%LAST_NAME%-%‘s separation from service and (ii) under the terms of this Agreement would be payable prior to the six-month anniversary of %%LAST_NAME%-%‘s separation from service, such payment shall be delayed until the earlier to occur of (a) the six-month anniversary of the separation from service and (b) the date of %%LAST_NAME%-%‘s death.

 

8. Binding Effect. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators, successors and assigns.

 

4


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed on the day and year first above written.

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

By:    
Name:    
 
 
 

        %%FIRST_NAME%-%         %%LAST_NAME%-%

 

5


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/22  Veradigm Inc.                     10-K/A     12/31/21   12:4M                                     Donnelley … Solutions/FA
 2/25/22  Veradigm Inc.                     10-K       12/31/21  150:28M                                    Donnelley … Solutions/FA
 2/26/21  Veradigm Inc.                     10-K       12/31/20  165:35M                                    ActiveDisclosure/FA
Top
Filing Submission 0001193125-11-216590   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 12:47:57.1pm ET